Indeed, two facts explain the inefficiency of T-helpers in tumor control: first, solid tumors do not express MHC class II, and therefore cannot directly stimulate CD4+ T cells, and second, tumor cells must be degraded by professional antigen-presenting cells (APCs) to be presented to T cells for action. The gene discussed is CD4; the disease is neoplasm.